APA
Maher V. E., Fernandes L. L., Weinstock C., Tang S., Agarwal S., Brave M., Ning Y., Singh H., Suzman D., Xu J., Goldberg K. B., Sridhara R., Ibrahim A., Theoret M., Beaver J. A. & Pazdur R. (20200610). Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Maher V Ellen, Fernandes Laura L, Weinstock Chana, Tang Shenghui, Agarwal Sundeep, Brave Michael, Ning Yang-Min, Singh Harpreet, Suzman Daniel, Xu James, Goldberg Kirsten B, Sridhara Rajeshwari, Ibrahim Amna, Theoret Marc, Beaver Julia A and Pazdur Richard. 20200610. Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Maher V. E., Fernandes L. L., Weinstock C., Tang S., Agarwal S., Brave M., Ning Y., Singh H., Suzman D., Xu J., Goldberg K. B., Sridhara R., Ibrahim A., Theoret M., Beaver J. A. and Pazdur R. (20200610). Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Maher V Ellen, Fernandes Laura L, Weinstock Chana, Tang Shenghui, Agarwal Sundeep, Brave Michael, Ning Yang-Min, Singh Harpreet, Suzman Daniel, Xu James, Goldberg Kirsten B, Sridhara Rajeshwari, Ibrahim Amna, Theoret Marc, Beaver Julia A and Pazdur Richard. Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20200610.